The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Acute Myeloid Leukemia Market Research Report 2025
Synopsis
Acute myeloid leukemia (AML) is a type of blood cancer. Learn more about AML causes, symptoms, diagnosis, and treatment.
The global Acute Myeloid Leukemia market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Acute Myeloid Leukemia, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Acute Myeloid Leukemia.
Report Scope
The Acute Myeloid Leukemia market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Acute Myeloid Leukemia market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Acute Myeloid Leukemia companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GSK
Novartis
Roche
Bristol-Myers Squibb
Celgene
Clavis Pharma ASA
Daiichi Sankyo
Eisai
Teva
Sunesis Pharmaceuticals
Segment by Type
Chemotherapy
Targeted Therapy
Segment by Application
Adults
Children
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Acute Myeloid Leukemia companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Acute myeloid leukemia (AML) is a type of blood cancer. Learn more about AML causes, symptoms, diagnosis, and treatment.
The global Acute Myeloid Leukemia market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Acute Myeloid Leukemia, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Acute Myeloid Leukemia.
Report Scope
The Acute Myeloid Leukemia market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Acute Myeloid Leukemia market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Acute Myeloid Leukemia companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GSK
Novartis
Roche
Bristol-Myers Squibb
Celgene
Clavis Pharma ASA
Daiichi Sankyo
Eisai
Teva
Sunesis Pharmaceuticals
Segment by Type
Chemotherapy
Targeted Therapy
Segment by Application
Adults
Children
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Acute Myeloid Leukemia companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Acute Myeloid Leukemia Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Chemotherapy
1.2.3 Targeted Therapy
1.3 Market by Application
1.3.1 Global Acute Myeloid Leukemia Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Adults
1.3.3 Children
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Acute Myeloid Leukemia Market Perspective (2019-2030)
2.2 Acute Myeloid Leukemia Growth Trends by Region
2.2.1 Global Acute Myeloid Leukemia Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Acute Myeloid Leukemia Historic Market Size by Region (2019-2024)
2.2.3 Acute Myeloid Leukemia Forecasted Market Size by Region (2025-2030)
2.3 Acute Myeloid Leukemia Market Dynamics
2.3.1 Acute Myeloid Leukemia Industry Trends
2.3.2 Acute Myeloid Leukemia Market Drivers
2.3.3 Acute Myeloid Leukemia Market Challenges
2.3.4 Acute Myeloid Leukemia Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Acute Myeloid Leukemia Players by Revenue
3.1.1 Global Top Acute Myeloid Leukemia Players by Revenue (2019-2024)
3.1.2 Global Acute Myeloid Leukemia Revenue Market Share by Players (2019-2024)
3.2 Global Acute Myeloid Leukemia Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Acute Myeloid Leukemia Revenue
3.4 Global Acute Myeloid Leukemia Market Concentration Ratio
3.4.1 Global Acute Myeloid Leukemia Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Acute Myeloid Leukemia Revenue in 2023
3.5 Acute Myeloid Leukemia Key Players Head office and Area Served
3.6 Key Players Acute Myeloid Leukemia Product Solution and Service
3.7 Date of Enter into Acute Myeloid Leukemia Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Acute Myeloid Leukemia Breakdown Data by Type
4.1 Global Acute Myeloid Leukemia Historic Market Size by Type (2019-2024)
4.2 Global Acute Myeloid Leukemia Forecasted Market Size by Type (2025-2030)
5 Acute Myeloid Leukemia Breakdown Data by Application
5.1 Global Acute Myeloid Leukemia Historic Market Size by Application (2019-2024)
5.2 Global Acute Myeloid Leukemia Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Acute Myeloid Leukemia Market Size (2019-2030)
6.2 North America Acute Myeloid Leukemia Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Acute Myeloid Leukemia Market Size by Country (2019-2024)
6.4 North America Acute Myeloid Leukemia Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Acute Myeloid Leukemia Market Size (2019-2030)
7.2 Europe Acute Myeloid Leukemia Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Acute Myeloid Leukemia Market Size by Country (2019-2024)
7.4 Europe Acute Myeloid Leukemia Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Acute Myeloid Leukemia Market Size (2019-2030)
8.2 Asia-Pacific Acute Myeloid Leukemia Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Acute Myeloid Leukemia Market Size by Region (2019-2024)
8.4 Asia-Pacific Acute Myeloid Leukemia Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Acute Myeloid Leukemia Market Size (2019-2030)
9.2 Latin America Acute Myeloid Leukemia Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Acute Myeloid Leukemia Market Size by Country (2019-2024)
9.4 Latin America Acute Myeloid Leukemia Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Acute Myeloid Leukemia Market Size (2019-2030)
10.2 Middle East & Africa Acute Myeloid Leukemia Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Acute Myeloid Leukemia Market Size by Country (2019-2024)
10.4 Middle East & Africa Acute Myeloid Leukemia Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Detail
11.1.2 GSK Business Overview
11.1.3 GSK Acute Myeloid Leukemia Introduction
11.1.4 GSK Revenue in Acute Myeloid Leukemia Business (2019-2024)
11.1.5 GSK Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis Acute Myeloid Leukemia Introduction
11.2.4 Novartis Revenue in Acute Myeloid Leukemia Business (2019-2024)
11.2.5 Novartis Recent Development
11.3 Roche
11.3.1 Roche Company Detail
11.3.2 Roche Business Overview
11.3.3 Roche Acute Myeloid Leukemia Introduction
11.3.4 Roche Revenue in Acute Myeloid Leukemia Business (2019-2024)
11.3.5 Roche Recent Development
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Detail
11.4.2 Bristol-Myers Squibb Business Overview
11.4.3 Bristol-Myers Squibb Acute Myeloid Leukemia Introduction
11.4.4 Bristol-Myers Squibb Revenue in Acute Myeloid Leukemia Business (2019-2024)
11.4.5 Bristol-Myers Squibb Recent Development
11.5 Celgene
11.5.1 Celgene Company Detail
11.5.2 Celgene Business Overview
11.5.3 Celgene Acute Myeloid Leukemia Introduction
11.5.4 Celgene Revenue in Acute Myeloid Leukemia Business (2019-2024)
11.5.5 Celgene Recent Development
11.6 Clavis Pharma ASA
11.6.1 Clavis Pharma ASA Company Detail
11.6.2 Clavis Pharma ASA Business Overview
11.6.3 Clavis Pharma ASA Acute Myeloid Leukemia Introduction
11.6.4 Clavis Pharma ASA Revenue in Acute Myeloid Leukemia Business (2019-2024)
11.6.5 Clavis Pharma ASA Recent Development
11.7 Daiichi Sankyo
11.7.1 Daiichi Sankyo Company Detail
11.7.2 Daiichi Sankyo Business Overview
11.7.3 Daiichi Sankyo Acute Myeloid Leukemia Introduction
11.7.4 Daiichi Sankyo Revenue in Acute Myeloid Leukemia Business (2019-2024)
11.7.5 Daiichi Sankyo Recent Development
11.8 Eisai
11.8.1 Eisai Company Detail
11.8.2 Eisai Business Overview
11.8.3 Eisai Acute Myeloid Leukemia Introduction
11.8.4 Eisai Revenue in Acute Myeloid Leukemia Business (2019-2024)
11.8.5 Eisai Recent Development
11.9 Teva
11.9.1 Teva Company Detail
11.9.2 Teva Business Overview
11.9.3 Teva Acute Myeloid Leukemia Introduction
11.9.4 Teva Revenue in Acute Myeloid Leukemia Business (2019-2024)
11.9.5 Teva Recent Development
11.10 Sunesis Pharmaceuticals
11.10.1 Sunesis Pharmaceuticals Company Detail
11.10.2 Sunesis Pharmaceuticals Business Overview
11.10.3 Sunesis Pharmaceuticals Acute Myeloid Leukemia Introduction
11.10.4 Sunesis Pharmaceuticals Revenue in Acute Myeloid Leukemia Business (2019-2024)
11.10.5 Sunesis Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Acute Myeloid Leukemia Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Chemotherapy
Table 3. Key Players of Targeted Therapy
Table 4. Global Acute Myeloid Leukemia Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Acute Myeloid Leukemia Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Acute Myeloid Leukemia Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Acute Myeloid Leukemia Market Share by Region (2019-2024)
Table 8. Global Acute Myeloid Leukemia Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Acute Myeloid Leukemia Market Share by Region (2025-2030)
Table 10. Acute Myeloid Leukemia Market Trends
Table 11. Acute Myeloid Leukemia Market Drivers
Table 12. Acute Myeloid Leukemia Market Challenges
Table 13. Acute Myeloid Leukemia Market Restraints
Table 14. Global Acute Myeloid Leukemia Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Acute Myeloid Leukemia Market Share by Players (2019-2024)
Table 16. Global Top Acute Myeloid Leukemia Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Myeloid Leukemia as of 2023)
Table 17. Ranking of Global Top Acute Myeloid Leukemia Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Acute Myeloid Leukemia Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Acute Myeloid Leukemia Product Solution and Service
Table 21. Date of Enter into Acute Myeloid Leukemia Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Acute Myeloid Leukemia Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Acute Myeloid Leukemia Revenue Market Share by Type (2019-2024)
Table 25. Global Acute Myeloid Leukemia Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Acute Myeloid Leukemia Revenue Market Share by Type (2025-2030)
Table 27. Global Acute Myeloid Leukemia Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Acute Myeloid Leukemia Revenue Market Share by Application (2019-2024)
Table 29. Global Acute Myeloid Leukemia Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Acute Myeloid Leukemia Revenue Market Share by Application (2025-2030)
Table 31. North America Acute Myeloid Leukemia Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Acute Myeloid Leukemia Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Acute Myeloid Leukemia Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Acute Myeloid Leukemia Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Acute Myeloid Leukemia Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Acute Myeloid Leukemia Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Acute Myeloid Leukemia Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Acute Myeloid Leukemia Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Acute Myeloid Leukemia Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Acute Myeloid Leukemia Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Acute Myeloid Leukemia Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Acute Myeloid Leukemia Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Acute Myeloid Leukemia Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Acute Myeloid Leukemia Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Acute Myeloid Leukemia Market Size by Country (2025-2030) & (US$ Million)
Table 46. GSK Company Detail
Table 47. GSK Business Overview
Table 48. GSK Acute Myeloid Leukemia Product
Table 49. GSK Revenue in Acute Myeloid Leukemia Business (2019-2024) & (US$ Million)
Table 50. GSK Recent Development
Table 51. Novartis Company Detail
Table 52. Novartis Business Overview
Table 53. Novartis Acute Myeloid Leukemia Product
Table 54. Novartis Revenue in Acute Myeloid Leukemia Business (2019-2024) & (US$ Million)
Table 55. Novartis Recent Development
Table 56. Roche Company Detail
Table 57. Roche Business Overview
Table 58. Roche Acute Myeloid Leukemia Product
Table 59. Roche Revenue in Acute Myeloid Leukemia Business (2019-2024) & (US$ Million)
Table 60. Roche Recent Development
Table 61. Bristol-Myers Squibb Company Detail
Table 62. Bristol-Myers Squibb Business Overview
Table 63. Bristol-Myers Squibb Acute Myeloid Leukemia Product
Table 64. Bristol-Myers Squibb Revenue in Acute Myeloid Leukemia Business (2019-2024) & (US$ Million)
Table 65. Bristol-Myers Squibb Recent Development
Table 66. Celgene Company Detail
Table 67. Celgene Business Overview
Table 68. Celgene Acute Myeloid Leukemia Product
Table 69. Celgene Revenue in Acute Myeloid Leukemia Business (2019-2024) & (US$ Million)
Table 70. Celgene Recent Development
Table 71. Clavis Pharma ASA Company Detail
Table 72. Clavis Pharma ASA Business Overview
Table 73. Clavis Pharma ASA Acute Myeloid Leukemia Product
Table 74. Clavis Pharma ASA Revenue in Acute Myeloid Leukemia Business (2019-2024) & (US$ Million)
Table 75. Clavis Pharma ASA Recent Development
Table 76. Daiichi Sankyo Company Detail
Table 77. Daiichi Sankyo Business Overview
Table 78. Daiichi Sankyo Acute Myeloid Leukemia Product
Table 79. Daiichi Sankyo Revenue in Acute Myeloid Leukemia Business (2019-2024) & (US$ Million)
Table 80. Daiichi Sankyo Recent Development
Table 81. Eisai Company Detail
Table 82. Eisai Business Overview
Table 83. Eisai Acute Myeloid Leukemia Product
Table 84. Eisai Revenue in Acute Myeloid Leukemia Business (2019-2024) & (US$ Million)
Table 85. Eisai Recent Development
Table 86. Teva Company Detail
Table 87. Teva Business Overview
Table 88. Teva Acute Myeloid Leukemia Product
Table 89. Teva Revenue in Acute Myeloid Leukemia Business (2019-2024) & (US$ Million)
Table 90. Teva Recent Development
Table 91. Sunesis Pharmaceuticals Company Detail
Table 92. Sunesis Pharmaceuticals Business Overview
Table 93. Sunesis Pharmaceuticals Acute Myeloid Leukemia Product
Table 94. Sunesis Pharmaceuticals Revenue in Acute Myeloid Leukemia Business (2019-2024) & (US$ Million)
Table 95. Sunesis Pharmaceuticals Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Acute Myeloid Leukemia Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Acute Myeloid Leukemia Market Share by Type: 2023 VS 2030
Figure 3. Chemotherapy Features
Figure 4. Targeted Therapy Features
Figure 5. Global Acute Myeloid Leukemia Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Acute Myeloid Leukemia Market Share by Application: 2023 VS 2030
Figure 7. Adults Case Studies
Figure 8. Children Case Studies
Figure 9. Acute Myeloid Leukemia Report Years Considered
Figure 10. Global Acute Myeloid Leukemia Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 11. Global Acute Myeloid Leukemia Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Acute Myeloid Leukemia Market Share by Region: 2023 VS 2030
Figure 13. Global Acute Myeloid Leukemia Market Share by Players in 2023
Figure 14. Global Top Acute Myeloid Leukemia Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Myeloid Leukemia as of 2023)
Figure 15. The Top 10 and 5 Players Market Share by Acute Myeloid Leukemia Revenue in 2023
Figure 16. North America Acute Myeloid Leukemia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 17. North America Acute Myeloid Leukemia Market Share by Country (2019-2030)
Figure 18. United States Acute Myeloid Leukemia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. Canada Acute Myeloid Leukemia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Europe Acute Myeloid Leukemia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Acute Myeloid Leukemia Market Share by Country (2019-2030)
Figure 22. Germany Acute Myeloid Leukemia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. France Acute Myeloid Leukemia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. U.K. Acute Myeloid Leukemia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Italy Acute Myeloid Leukemia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Russia Acute Myeloid Leukemia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Nordic Countries Acute Myeloid Leukemia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Asia-Pacific Acute Myeloid Leukemia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Acute Myeloid Leukemia Market Share by Region (2019-2030)
Figure 30. China Acute Myeloid Leukemia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Japan Acute Myeloid Leukemia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. South Korea Acute Myeloid Leukemia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Southeast Asia Acute Myeloid Leukemia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. India Acute Myeloid Leukemia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Australia Acute Myeloid Leukemia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Latin America Acute Myeloid Leukemia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Acute Myeloid Leukemia Market Share by Country (2019-2030)
Figure 38. Mexico Acute Myeloid Leukemia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Brazil Acute Myeloid Leukemia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Middle East & Africa Acute Myeloid Leukemia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Acute Myeloid Leukemia Market Share by Country (2019-2030)
Figure 42. Turkey Acute Myeloid Leukemia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Saudi Arabia Acute Myeloid Leukemia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. GSK Revenue Growth Rate in Acute Myeloid Leukemia Business (2019-2024)
Figure 45. Novartis Revenue Growth Rate in Acute Myeloid Leukemia Business (2019-2024)
Figure 46. Roche Revenue Growth Rate in Acute Myeloid Leukemia Business (2019-2024)
Figure 47. Bristol-Myers Squibb Revenue Growth Rate in Acute Myeloid Leukemia Business (2019-2024)
Figure 48. Celgene Revenue Growth Rate in Acute Myeloid Leukemia Business (2019-2024)
Figure 49. Clavis Pharma ASA Revenue Growth Rate in Acute Myeloid Leukemia Business (2019-2024)
Figure 50. Daiichi Sankyo Revenue Growth Rate in Acute Myeloid Leukemia Business (2019-2024)
Figure 51. Eisai Revenue Growth Rate in Acute Myeloid Leukemia Business (2019-2024)
Figure 52. Teva Revenue Growth Rate in Acute Myeloid Leukemia Business (2019-2024)
Figure 53. Sunesis Pharmaceuticals Revenue Growth Rate in Acute Myeloid Leukemia Business (2019-2024)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
